Overview

This trial is active, not recruiting.

Conditions helicobacter pylori, eradication, gastric cancer, medical care cost
Sponsor Showa Inan General Hospital
Start date September 2007
End date August 2017
Trial size 3000 participants
Trial identifier NCT00596401, sihp20076

Summary

Recently, the preventive effect of Helicobacter pylori (Hp) eradication treatment on the incidence of gastric cancer has been reported. By Hp eradication treatment being performed for Hp-infected people in Iijima town, we will evaluate whether the incidence of gastric cancer and/or the medical care cost can be reduced as compared with those in the previous years.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Arm
HP eradication group
No eradication group
No Hp group

Primary Outcomes

Measure
the annual incidence of gastric cancer in Iijima town
time frame: 10 years

Secondary Outcomes

Measure
The annual medical care cost in Iijima town
time frame: 10 years

Eligibility Criteria

Male or female participants from 19 years up to 69 years old.

Inclusion Criteria: - People who live in Iijima town at their age of 19 to 69 years

Additional Information

Official title The Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer and the Medical Care Cost in Iijima Town
Trial information was received from ClinicalTrials.gov and was last updated in April 2016.
Information provided to ClinicalTrials.gov by Showa Inan General Hospital.